video1.0<iframe src="https://www.loom.com/embed/a17dfa5b948c4dcd8bd6e20201c9d206" frameborder="0" width="1728" height="1296" webkitallowfullscreen mozallowfullscreen allowfullscreen></iframe>12961728Loomhttps://www.loom.com12961728https://cdn.loom.com/sessions/thumbnails/a17dfa5b948c4dcd8bd6e20201c9d206-ebc586c734f7c138.gif344.3279In this video, I walk you through my project focused on analyzing the BRCA1 gene, which is crucial for understanding breast cancer risk, particularly in African populations where existing models are biased. I demonstrate how our model predicts whether a gene variant is likely benign, showcasing a confidence level of 60%. Our testing results indicate a high performance, with unit testing at 96% and end-to-end testing at 100%. I also highlight the potential cost savings of up to $1.6 million through this model. I encourage you to navigate to the Capstone site to explore and utilize this application further.